The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
<p>Abstract</p> <p>Background</p> <p>Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2013-02-01
|
| Schriftenreihe: | BMC Cancer |
| Schlagworte: | |
| Online-Zugang: | http://www.biomedcentral.com/1471-2407/13/50 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
